X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (75448) 75448
Newsletter (1111) 1111
Newspaper Article (584) 584
Book Chapter (327) 327
Magazine Article (158) 158
Dissertation (123) 123
Transcript (77) 77
Publication (69) 69
Book / eBook (34) 34
Conference Proceeding (31) 31
Reference (27) 27
Book Review (8) 8
Web Resource (6) 6
Journal / eJournal (4) 4
Streaming Video (4) 4
Paper (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58267) 58267
male (26976) 26976
female (26119) 26119
middle aged (20618) 20618
oncology (18098) 18098
aged (17897) 17897
adult (16076) 16076
hematology (15638) 15638
animals (11973) 11973
lymphomas (11444) 11444
b-cell lymphoma (11197) 11197
lymphoma (9814) 9814
cancer (9440) 9440
prognosis (7818) 7818
mice (7734) 7734
b cells (7680) 7680
lymphoma, large b-cell, diffuse - pathology (7415) 7415
expression (7150) 7150
aged, 80 and over (7075) 7075
immunology (6897) 6897
rituximab (6782) 6782
lymphoma, b-cell - pathology (6300) 6300
pathology (6294) 6294
chemotherapy (6026) 6026
antineoplastic combined chemotherapy protocols - therapeutic use (5760) 5760
adolescent (5670) 5670
apoptosis (5654) 5654
non-hodgkins-lymphoma (5485) 5485
treatment outcome (5422) 5422
research (5362) 5362
leukemia (5319) 5319
immunohistochemistry (4789) 4789
lymphocytes b (4765) 4765
lymphoma, large b-cell, diffuse - drug therapy (4638) 4638
hemic and lymphatic diseases (4587) 4587
child (4277) 4277
survival (4124) 4124
care and treatment (4122) 4122
b-cells (4062) 4062
diagnosis, differential (4024) 4024
gene expression (3943) 3943
analysis (3939) 3939
b-lymphocytes - immunology (3877) 3877
diagnosis (3816) 3816
lymphocytes (3800) 3800
health aspects (3781) 3781
cell biology (3742) 3742
therapy (3696) 3696
flow cytometry (3645) 3645
retrospective studies (3605) 3605
lymphoma, large b-cell, diffuse - diagnosis (3562) 3562
proteins (3513) 3513
genetic aspects (3474) 3474
chronic lymphocytic-leukemia (3452) 3452
disease (3355) 3355
cell line, tumor (3347) 3347
leukemia, lymphocytic, chronic, b-cell - pathology (3281) 3281
tumors (3271) 3271
antineoplastic agents - therapeutic use (3233) 3233
diffuse large b-cell lymphoma (3227) 3227
lymphoma, b-cell - genetics (3208) 3208
mutation (3127) 3127
activation (3126) 3126
biopsy (3001) 3001
tumor cells, cultured (2903) 2903
medicine, research & experimental (2885) 2885
immunophenotyping (2877) 2877
chronic lymphocytic leukemia (2864) 2864
lymphoma, b-cell - drug therapy (2859) 2859
young adult (2793) 2793
t cells (2791) 2791
lymphoma, large b-cell, diffuse - genetics (2782) 2782
non-hodgkin's lymphomas (2721) 2721
b-cell (2718) 2718
medicine & public health (2713) 2713
abridged index medicus (2672) 2672
leukemia, lymphocytic, chronic, b-cell - drug therapy (2665) 2665
immunotherapy (2637) 2637
signal transduction (2610) 2610
polymerase chain reaction (2596) 2596
biochemistry & molecular biology (2595) 2595
lymphoma, b-cell - diagnosis (2580) 2580
neoplasm staging (2566) 2566
risk factors (2563) 2563
leukemia, lymphocytic, chronic, b-cell - genetics (2530) 2530
lymphoma, b-cell - immunology (2524) 2524
lymphoma, b-cell, marginal zone - pathology (2518) 2518
child, preschool (2511) 2511
follicular lymphoma (2436) 2436
immune system diseases (2434) 2434
patients (2412) 2412
follow-up studies (2393) 2393
gene (2390) 2390
neoplasms (2342) 2342
research article (2332) 2332
classification (2304) 2304
antibodies, monoclonal - therapeutic use (2299) 2299
lymphoma, non-hodgkin - pathology (2280) 2280
b-lymphocytes - metabolism (2270) 2270
lymphoma, large b-cell, diffuse (2264) 2264
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (70704) 70704
Japanese (1531) 1531
German (1472) 1472
French (1374) 1374
Chinese (1020) 1020
Spanish (692) 692
Italian (673) 673
Russian (671) 671
Polish (236) 236
Korean (226) 226
Czech (91) 91
Hungarian (89) 89
Portuguese (80) 80
Dutch (56) 56
Danish (55) 55
Romanian (55) 55
Turkish (41) 41
Serbian (29) 29
Croatian (20) 20
Swedish (19) 19
Bulgarian (18) 18
Hebrew (17) 17
Norwegian (17) 17
Slovak (17) 17
Finnish (13) 13
Persian (6) 6
Ukrainian (6) 6
Lithuanian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Galician (1) 1
Greek (1) 1
Indonesian (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | TRANSFORMATION | SURGERY | TRANSLOCATION | T(14/18) | T(14-18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | ACUTE LYMPHOBLASTIC-LEUKEMIA | EXPRESSION | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Summary Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | AFRICAN CHILDREN | PLASMODIUM-FALCIPARUM | ACUTE LYMPHOBLASTIC-LEUKEMIA | B-CELL LYMPHOMAS | ACTIVE ANTIRETROVIRAL THERAPY | C-MYC | NON-HODGKINS-LYMPHOMA | EPSTEIN-BARR-VIRUS | CHILDRENS ONCOLOGY GROUP | ACUTE MALARIA | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors
Journal Article
Southern Medical Journal, ISSN 0038-4348, 10/2017, Volume 110, Issue 10, pp. 614 - 620
... of these malignancies with a special focus on lymphomas. To our knowledge this is one of the largest and most comprehensive studies of breast hematologic malignancies... 
PRIMARY LYMPHOSARCOMA | IMPLANT CAPSULE | secondary breast lymphoma | diffuse large B-cell lymphoma | LARGE-CELL LYMPHOMA | CANCER | WOMEN | MEDICINE, GENERAL & INTERNAL | primary breast lymphoma | THERAPY | follicular lymphoma of the breast | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | SOFT-TISSUE SARCOMA | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Breast Neoplasms - secondary | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Hematologic Neoplasms - pathology | Plasmacytoma - pathology | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Aged, 80 and over | Adult | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Hematologic Neoplasms - diagnosis | Sarcoma, Myeloid - pathology | Diagnosis, Differential | Lymphoma - diagnosis | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Carcinoma - diagnosis | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Plasmacytoma - diagnosis | Lymphoma, Large B-Cell, Diffuse - diagnosis | Animals | Lymphoma, B-Cell, Marginal Zone - diagnosis | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Breast Neoplasms - pathology | Lymphoma, T-Cell - diagnosis | Lymphoma, T-Cell - pathology | Aged | Breast Neoplasms - diagnosis | Lymphoma, Large-Cell, Anaplastic - pathology | Sarcoma, Myeloid - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Journal Article
Investigational new drugs, ISSN 1573-0646, 2018, Volume 37, Issue 2, pp. 297 - 306
...) dimer, in patients with relapsed or refractory (R/R) CD70-positive non-Hodgkin lymphoma (NHL... 
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Diffuse | large B cell | ONCOLOGY | lymphoma (DLBCL) | PLUS RITUXIMAB | PHARMACOLOGY & PHARMACY | OUTCOMES | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism | Lymphoma, B-Cell - drug therapy | CD27 Ligand - immunology | Lymphoma, B-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Recurrence, Local - metabolism | Antibodies, Monoclonal - pharmacokinetics | Lymphoma, Mantle-Cell - drug therapy | Maximum Tolerated Dose | Lymphoma, Mantle-Cell - immunology | Lymphoma, B-Cell - pathology | Benzodiazepines - chemistry | Pyrroles - chemistry | Aged | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Complications and side effects | Genetic aspects | Dosage and administration | Non-Hodgkin's lymphomas | Research | Drug therapy | Antineoplastic agents | Thrombocytopenia | Anemia | Fatigue | Nausea | Exposure | Lymphoma | Patients | Anticancer properties | Membrane proteins | Proteins | Studies | Lymphocytes B | Mantle cell lymphoma | Antitumor activity | Remission | Lymphomas | Dimers | Mantle | Drug dosages | B-cell lymphoma | Phase I Studies
Journal Article
American journal of hematology, ISSN 0361-8609, 2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | MULTIPLE-MYELOMA | chronic lymphocytic leukemia (CLL) | acute lymphoblastic leukemia (ALL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SOMATIC MUTATIONS | TRANSCRIPTIONAL FINGERPRINTS | diffuse large B-cell lymphoma (DLBCL) | burkitt lymphoma (BL) | BURKITT-LYMPHOMA | gene regulation | circular RNA | POOR-PROGNOSIS | PROFILING REVEALS | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM) | EXPRESSION | PROMOTES | LNCRNA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1116 - 1120
Journal Article